AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases
Master One Thing - Rapamycin Longevity Series
Plans for the Rapa Mysen trial and considerations for the study population
Discussion on plans to start the Rapa Mysen trial, which aims to examine a wide range of aging parameters, with a focus on inflammatory markers. The chapter also mentions the potential positive response of older individuals in similar studies.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode